PET ligands developed to bind tau neurofibrillary tangles in AD showed increase uptake also in bvFTD due to hexanucleotide repeat expansion in C9orf72, associated with TDP-43 deposition [12]. The gene discussed is MAPT; the disease is Alzheimer disease.